Piper Jaffray has hired Mihir Mantri and Paul Scansaroli as managing directors in its Investment Banking division.
Mantri will join the healthcare investment banking group and advise life sciences companies. Scansaroli will join the equity capital markets group with a focus on high growth companies across the healthcare sector. Both will be based in the firm’s New York office.
Prior to joining Piper Jaffray, Mantri served as managing director and head of life sciences at BMO Capital Markets, where he led banking coverage for the biotechnology sector. Earlier in his career, Mantri worked at Jefferies in healthcare investment banking.
“Mihir’s significant experience and talents will add tremendous value to our healthcare investment banking platform,” said J.P. Peltier, global group head of healthcare investment banking at Piper Jaffray. “We are very proud of our success in building a practice based on deep, long-term and trusted relationships with our clients. Mihir’s dedication to delivering the highest-caliber advice fits squarely within the Piper Jaffray culture.”
Prior to joining Piper Jaffray, Scansaroli was a managing director and co-head of healthcare equity capital markets at Barclays where he drove significant growth in the Barclays life sciences equity practice. Scansaroli previously served in healthcare equity capital markets at Lehman Brothers.
“Paul’s addition represents strategic growth to our healthcare capital markets practice,” added David Stadinski, global head of equity capital markets at Piper Jaffray. “We are thrilled to welcome him to our platform.”
